Events

From December 5th to 8th, 2024, we participated in the Healthcare Expo Taiwan in Taipei, where our ability to simplify and automate the NGS workflow left a deep impression on many attendees. Numerous international distributors and reagent companies also expressed strong interest in potential collaborations during the event.Our mission is to bring NGS testing directly to hospitals, eliminating the need for sample outsourcing. With our streamlined One-stop NGS Solution—covering everything from sample analysis to report generation—we are transforming healthcare by enhancing accessibility, efficiency, and quality.We look forward to collaborating with global partners to drive advancements in precision medicine and make innovative diagnostics more accessible worldwide.

Discover the Secret to Scaling from 0 to 1,500 Tests! Are you a distributor or hospital administrator? Don't miss this exclusive webinar where we share the proven strategies behind establishing clinical NGS testing services in leading hospitals.Date: November 26th, 2024Asia: 04:00 PM (GMT+8)Europe: 09:00 AM (GMT+1)Register Now: https://reurl.cc/Gpz10D

 Join us at 主題標籤MEDICA 2024 – Hall 13, Stand A63! We'll be showcasing our INVISION Leukemia Embedded Precision Medicine Solution , a cutting-edge gene mutation detection platform designed for 主題標籤AML, 主題標籤CML, and other hematological malignancies. This automated system seamlessly integrates into clinical workflows, saving time and improving treatment accuracy! 

We're beyond excited to be at MEDICA2024, reconnecting with friends and making new ones from all over the globe! If you're searching for an ultrasensitive blood test platform for Alzheimer's detection, swing by our booth at HALL16, TaiwanPavilion, Booth E-02! We'd love to show you how our technology can be the missing link in your diagnostics journey. Let's explore the path forward—together!

We're excited to participate in the Alzheimer’s Association® International Conference (AAIC) 2024 from July 28 to July 31. Explore our latest technologies:True-to-Nature Drug/ Antibody FOPPR Characterization: Gain in-depth insights into molecular interactions with our advanced analysis, including drug structure and IVD antibody pair selection.Ultra Sensitivity FONLISA Detection: Experience exceptional performance with a compact design and unparalleled sensitivity, with a limit of detection (LOD) of ~fg/ml.